NGO Funds India

BIRAC GCI — Screening & Diagnosis Innovations Open Call

BIRAC · Central government · Verified 3 August 2026

BIRAC GCI grant funds up to ₹2 crore for breakthrough screening and diagnostics innovations in TB, emerging pathogens, and enteric disease.

Closed. Applications closed on 1 July 2026. The details below describe the most recent cycle.

Key facts

Grant size
Up to ₹2 crore
Funding type
Grant
Deadline
1 July 2026
Disbursement
Paid in tranches

About this program

This Open Call, run under Grand Challenges India (GCI–BIRAC) by the Biotechnology Industry Research Assistance Council (BIRAC) under the Department of Biotechnology, Govt of India, backs indigenous innovations and transformative solutions in four priority infectious disease areas — tuberculosis, emerging pathogens, syndromic panels and enteric pathogens. The call focuses on high-risk, high-reward innovations for screening and diagnostics, with an emphasis on near point-of-care and ultra-low-cost solutions designed to significantly improve accessibility and availability.

The Call offers two funding tiers. The Exploratory tier provides up to ₹50 lakh over a 12-month duration for high-risk early proposals. The Solution / Innovation / Product / Technology tier provides up to ₹2 crore over an 18-month duration for proposals advancing toward product or technology development and deployment.

The Call is open to a broad set of applicants: Indian academic and research institutions, public and private R&D organisations, start-ups, and not-for-profit foundations. Multidisciplinary partnerships and consortia-based applications are strongly encouraged — academic, clinical and industry-led collaborations are explicitly welcomed.

Beyond direct funding, awardees receive technical handholding from BIRAC / GCI and access to scale-up and deployment pathways. Applications must be submitted through the BIRAC online portal only; applicants need to register on the BIRAC portal first. The Call was announced on 12 May 2026 and applications close on 1 July 2026 at 2:00 PM IST.

Who can apply

Eligible organisation types
All nonprofit forms
12A registration
Not specified
80G registration
Not specified
CSR-1 registration
Not specified
FCRA registration
Not specified
NGO Darpan ID
Not specified
Where the NGO may be based
Not restricted
  • Indian academic and research institutions
  • Public and private R&D organisations
  • Start-ups incorporated in India
  • Not-for-profit foundations
  • Multidisciplinary partnerships and consortia-based applications strongly encouraged (academic + clinical + industry collaborations)
  • Focus area must align with the Call's priority infectious disease themes: tuberculosis, emerging pathogens, syndromic panels, or enteric pathogens
  • Innovations should target screening and / or diagnostics, preferably near point-of-care, ultra-low-cost solutions
  • High-risk, high-reward proposals encouraged

How to apply

  • Create an account on the BIRAC online portal (birac.nic.in) to receive login credentials.
  • Review the complete RFP document available on the BIRAC Call for Proposals page for details on proposal format, evaluation criteria, and tier-specific instructions.
  • Draft the proposal using the prescribed BIRAC template, incorporating a budget breakdown and a milestone plan.
  • Submit the proposal through the BIRAC online portal, selecting the appropriate tier (Exploratory or Solution / Innovation / Product / Technology).
  • An expert or scientific committee assesses the proposal.
  • Successful applicants are informed; a funding agreement is executed, and disbursement proceeds in instalments tied to milestones.
  • Submission deadline: 1 July 2026, 2:00 PM IST.

Apply on the funder's site

How applications are assessed

Expert panels and scientific committees assembled by BIRAC and Grand Challenges India examine all submitted proposals. Their assessment weighs scientific merit, the quality of innovation, practical feasibility, and the potential public-health effect, with particular attention to how accessible and affordable the proposed screening or diagnostic tools would be. The capability of the applicant team and the robustness of any multidisciplinary or consortium arrangements also factor into the decision.

Successful applicants then sign a funding agreement with BIRAC. Disbursement of funds is tied to the achievement of project milestones, spread across 12 months for the Exploratory tier and 18 months for the Solution or Product tier.

Frequently asked questions

Who can apply for this BIRAC GCI Call?

Indian academic and research institutions, public and private R&D organisations, start-ups incorporated in India, and not-for-profit foundations are eligible. Multidisciplinary and consortia-based applications combining academic, clinical, and industry partners are encouraged.

How much funding does the Call offer?

The programme has two support tiers: an Exploratory tier offering up to ₹50 lakh for a maximum of 12 months, and a Solution / Innovation / Product / Technology tier providing up to ₹2 crore for up to 18 months.

What focus areas are eligible?

The programme funds innovations in screening and diagnostics for four priority infectious disease areas: tuberculosis, emerging pathogens, syndromic panels, and enteric pathogens. Emphasis is placed on near point-of-care and ultra-low-cost solutions.

Does BIRAC take equity in selected projects?

No. The Grand Challenges India scheme provides non-dilutive grants, and BIRAC does not acquire equity in the organisations it supports.

Can not-for-profit foundations and NGOs apply?

Yes. Not-for-profit foundations are eligible to apply, as are academic and research institutions, R&D organisations, and start-ups.

Are consortia required?

Consortia are encouraged but not mandatory, with the Call highlighting the value of multidisciplinary collaboration among academic, clinical and industry partners.

What is the application deadline?

Applications close at 2:00 PM IST on 1 July 2026. The call was announced on 12 May 2026.

Focus areas

  • Health Pharma Biotech
  • Birac
  • Grand Challenges India
  • Gci
  • Dbt
  • Department Of Biotechnology
  • Diagnostics
  • Screening
  • Infectious Diseases
  • Tuberculosis
  • Healthtech
  • Biotech
  • Central Government
  • Equityfree
  • Consortia
  • Academic
  • Research
  • Ngo Eligible

Details last verified on 3 August 2026. Source: the funder's published information.

GrantNetwork or intermediaryOpen for applications

SheConnects Digital Accelerator India 2026 (Round 2)

Reliance Foundation

Grants and support for not-for-profits scaling proven solutions to advance women's digital inclusion across India.

Grant size
₹85 lakh – ₹4.2 crore
Deadline
4 September 2026
Time left
19 days

Fintech · Health Pharma Biotech · Agri Food Rural · Edtech

PrizeForeign foundationOpen for applications

The Wellcome Prize for Mental Health Science with Nature

Wellcome

The Wellcome-Nature Mental Health Prize funds groundbreaking mental health science, awarding up to ₹9.52 crore to the winner and ₹2.38 crore to finalists, plus visibility and support.

Grant size
₹2.38 crore – ₹9.53 crore
Deadline
15 September 2026
Time left
29 days

Health Pharma Biotech · Social Impact · Mental Health · Science

PrizeForeign foundationOpen for applications

The Wellcome Snakebite Innovation Prize

Wellcome

A global challenge prize awarding up to £6.25 million (approx. ₹65.6 crore) to multi-disciplinary teams developing innovative solutions for snakebite outcomes in high-burden settings.

Grant size
₹78.75 lakh – ₹18.38 crore
Deadline
16 September 2026
Time left
31 days

Health Pharma Biotech · Social Impact · Healthtech · Global Health